Literature DB >> 7633836

Effects of human papillomavirus type-specific antisense oligonucleotides on cervical cancer cells containing papillomavirus type 16.

Y F Wong1, T K Chung, T H Cheung, S K Lam, A M Chang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7633836     DOI： 10.1007/bf02999867

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  12 in total

1.  Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer.

Authors:  P H Watson; R T Pon; R P Shiu
Journal:  Cancer Res       Date:  1991-08-01       Impact factor: 12.701

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 3.  Human papillomaviruses and genital cancer.

Authors:  H Pfister
Journal:  Adv Cancer Res       Date:  1987       Impact factor: 6.242

4.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.

Authors:  K Münger; W C Phelps; V Bubb; P M Howley; R Schlegel
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

5.  Enzymatic amplification of translation inhibition of rabbit beta-globin mRNA mediated by anti-messenger oligodeoxynucleotides covalently linked to intercalating agents.

Authors:  C Cazenave; N Loreau; N T Thuong; J J Toulmé; C Hélène
Journal:  Nucleic Acids Res       Date:  1987-06-25       Impact factor: 16.971

Review 6.  Oligonucleotide pharmacotherapy: an antigene strategy.

Authors:  K M Nagel; S G Holstad; K E Isenberg
Journal:  Pharmacotherapy       Date:  1993 May-Jun       Impact factor: 4.705

7.  Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.

Authors:  S Agrawal; J Temsamani; J Y Tang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

8.  Effect on cancer cells of plasmids that express antisense RNA of human papillomavirus type 18.

Authors:  C Steele; P G Sacks; K Adler-Storthz; E J Shillitoe
Journal:  Cancer Res       Date:  1992-09-01       Impact factor: 12.701

9.  Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells.

Authors:  M von Knebel Doeberitz; T Oltersdorf; E Schwarz; L Gissmann
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

10.  Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras.

Authors:  T Crook; J P Morgenstern; L Crawford; L Banks
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598
View more
  1 in total

Review 1.  Gene therapy for infectious diseases.

Authors:  B A Bunnell; R A Morgan
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.